Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,414 | 1,028 | 99.4% |
| Education | $94.99 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,097 | 133 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,270 | 96 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,110 | 48 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,062 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $954.79 | 118 | $0 (2024) |
| Encore Dermatology Inc. | $738.92 | 42 | $0 (2019) |
| GENZYME CORPORATION | $736.97 | 26 | $0 (2024) |
| Incyte Corporation | $601.83 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $580.83 | 26 | $0 (2024) |
| Allergan, Inc. | $571.02 | 30 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,822 | 227 | ABBVIE INC. ($501.29) |
| 2023 | $2,973 | 169 | AbbVie Inc. ($582.57) |
| 2022 | $2,027 | 162 | ABBVIE INC. ($383.54) |
| 2021 | $1,076 | 131 | VYNE Pharmaceuticals Inc. ($252.14) |
| 2020 | $913.62 | 81 | VYNE Pharmaceuticals Inc. ($242.19) |
| 2019 | $1,485 | 81 | Allergan Inc. ($287.35) |
| 2018 | $1,941 | 113 | Encore Dermatology Inc. ($479.01) |
| 2017 | $1,271 | 66 | GENZYME CORPORATION ($191.71) |
All Payment Transactions
1,030 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: DERMATOLOGY | ||||||
| 12/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Immunology | ||||||
| 12/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $2.45 | General |
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Inflammation & Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.37 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Immunology | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $2.23 | General |
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,706 | 2,671 | $473,549 | $152,316 |
| 2022 | 12 | 1,340 | 2,106 | $374,880 | $122,733 |
| 2021 | 15 | 1,373 | 2,223 | $372,501 | $127,074 |
| 2020 | 12 | 1,081 | 1,678 | $289,625 | $92,617 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 391 | 526 | $114,142 | $35,961 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 376 | $95,128 | $31,698 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 335 | 497 | $92,442 | $28,864 | 31.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 256 | 542 | $59,620 | $20,935 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 113 | 148 | $34,928 | $10,569 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 106 | 137 | $18,632 | $5,409 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,240 | $4,073 | 33.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 31 | $9,517 | $3,770 | 39.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $10,716 | $3,142 | 29.3% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 12 | 14 | $7,686 | $2,779 | 36.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 51 | $5,865 | $2,061 | 35.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 11 | 40 | $5,840 | $1,160 | 19.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 62 | 207 | $2,898 | $980.34 | 33.8% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 19 | $3,895 | $914.18 | 23.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 321 | 458 | $99,386 | $31,463 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 284 | 426 | $79,236 | $24,988 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 284 | $71,852 | $24,930 | 34.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 214 | 445 | $48,950 | $17,035 | 34.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 79 | 111 | $26,196 | $8,869 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $10,880 | $3,507 | 32.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 73 | 89 | $12,104 | $3,252 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $10,032 | $3,224 | 32.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 22 | $6,754 | $2,830 | 41.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 30 | 31 | $3,565 | $1,245 | 34.9% |
| 69100 | Biopsy of ear | Office | 2022 | 16 | 19 | $3,895 | $719.52 | 18.5% |
About Dr. Allison Singer, M.D
Dr. Allison Singer, M.D is a Dermatology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720086846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Singer, M.D has received a total of $15,509 in payments from pharmaceutical and medical device companies, with $3,822 received in 2024. These payments were reported across 1,030 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($15,414).
As a Medicare-enrolled provider, Singer has provided services to 5,500 Medicare beneficiaries, totaling 8,678 services with total Medicare billing of $494,740. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Plano, TX
- Active Since 07/12/2005
- Last Updated 08/07/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1720086846
Products in Payments
- DUPIXENT (Biological) $1,200
- SKYRIZI (Biological) $915.37
- TREMFYA (Drug) $665.38
- OPZELURA (Drug) $601.83
- Impoyz (Drug) $600.56
- VTAMA (Drug) $497.67
- ILUMYA (Biological) $473.15
- Otezla (Drug) $405.93
- TALTZ (Drug) $403.23
- RINVOQ (Biological) $394.27
- Winlevi (Drug) $358.25
- Humira (Biological) $350.94
- BOTOX COSMETIC (Biological) $309.09
- COSENTYX (Biological) $287.91
- COSENTYX (Drug) $266.77
- ZILXI (Drug) $254.40
- AMZEEQ (Drug) $239.93
- REMICADE (Biological) $235.46
- BOTOX (Biological) $226.69
- EUCRISA (Drug) $224.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Plano
Seemal Desai, Md, MD
Dermatology — Payments: $686,611
Dr. Natalie Wright, M.d, M.D
Dermatology — Payments: $346,490
Sam Awan, M.d, M.D
Dermatology — Payments: $322,018
Dr. Julie Rembold, M.d, M.D
Dermatology — Payments: $21,582
Nicholas Snavely, Md, MD
Dermatology — Payments: $18,034
Dr. Chris Crawford, M. D, M. D
Dermatology — Payments: $16,475